Hays Pharma is to open an office in Singapore.

The new office adds to the four other Hays Pharma offices in China (Shanghai, Beijing), Japan and Australia.

Martin Grindrod, manager of Hays Pharma in Singapore, says: “Singapore is one of the most open economies in the world and remains a popular trading base for the South East Asian region. The country is actively developing its pharmaceutical and biotechnology sectors, with funding earmarked to infrastructure, further research and development.

“We’ve seen several leading pharmaceutical companies set up operations in Singapore and they are investing considerable amounts of money in new facilities. Pharmaceuticals now account for more than 16% of the country’s manufacturing production.”